MicroPort NeuroTech Limited

Equities

2172

KYG6083E1098

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 04:08:20 2024-04-26 am EDT 5-day change 1st Jan Change
9.15 HKD +0.99% Intraday chart for MicroPort NeuroTech Limited +9.98% -25.25%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
MicroPort NeuroTech Limited Proposes Final Ordinary Dividend for the Year Ended 31 December 2023, Payable on 22 August 2024 CI
MicroPort NeuroTech Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Microport NeuroTech Forecasts Swing to Profit in 2023; Shares Rise 4% MT
MicroPort NeuroTech Limited Announces Executive Changes CI
Microport NeuroTech Buys Land for Global Headquarters in Shanghai MT
MicroPort NeuroTech Swings to H1 Profit Amid Revenue Boost MT
MicroPort NeuroTech Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
MicroPort NeuroTech Expects Swing to Profit in H1 MT
MicroPort NeuroTech Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023 CI
Certain Ordinary Shares of MicroPort NeuroTech Limited are subject to a Lock-Up Agreement Ending on 14-JUL-2023. CI
MicroPort NeuroTech Proposes New Share Scheme MT
MicroPort NeuroTech Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
MicroPort NeuroTech Expects Higher 2022 Profit, Revenue MT
Certain Ordinary Shares of MicroPort NeuroTech Limited are subject to a Lock-Up Agreement Ending on 14-JAN-2023. CI
MicroPort NeuroTech Limited(SEHK:2172) added to S&P Global BMI Index CI
Microport Neurotech Limited Announces Address Changes CI
MicroPort NeuroTech Swings to H1 Loss MT
MicroPort's Neuro-interventional Device Wins Marketing Nod in Japan MT
Microport Neurotech Limited Announces Approval of Numen Coil Embolization System by the Japanese Ministry of Health, Labour and Welfare for Final Marketing Authorisation CI
MicroPort NeuroTech's Hong Kong IPO Stabilization Ends with No Overallotment MT
MicroPort NeuroTech Ekes Out Slight Gain in Hong Kong Debut MT
MicroPort NeuroTech Limited has completed an IPO in the amount of HKD 337.568 million. CI
MicroPort NeuroTech Raises $35 Million in Xinhuanet-Backed Hong Kong IPO MT
MicroPort NeuroTech Limited has filed an IPO in the amount of HKD 337.568 million. CI
Chart MicroPort NeuroTech Limited
More charts
MicroPort NeuroTech Ltd is a China-based investment holding company. The company is principally engaged in the research and development, manufacturing and sales of neuro-interventional medical devices. The Company's main products include embolization coils, flow-diverting stents and stent grafts. The Company's products mainly cover three major areas of neurovascular diseases, namely hemorrhagic stroke, cerebral atherosclerotic stenosis and acute ischemic stroke. The Company mainly operates its businesses in the domestic and overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
8.47 CNY
Average target price
12.94 CNY
Spread / Average Target
+52.73%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 2172 Stock
  4. News MicroPort NeuroTech Limited
  5. MicroPort NeuroTech Raises $35 Million in Xinhuanet-Backed Hong Kong IPO